Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,15 USD | -3,15% | -24,29% | +65,62% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 145 mln. 136 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -33 mln. -30,94 mln. | Nettowinst (verlies) 2025 * | -46 mln. -43,13 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 94,2 mln. 88,32 mln. | Nettoliquiditeiten 2025 * | 50,8 mln. 47,63 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-4,37
x | K/w-verhouding 2025 * |
-3,64
x | Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,25% |
Recentste transcriptie over Regulus Therapeutics Inc.
1 dag | -2,48% | ||
1 week | -22,50% | ||
Lopende maand | -24,65% | ||
1 maand | -9,01% | ||
3 maanden | +77,87% | ||
6 maanden | +72,22% | ||
Lopend jaar | +69,53% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04-01-16 |
Preston Klassen
PSD | President | 55 | 22-06-23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30-08-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01-06-17 |
David Baltimore
BRD | Director/Board Member | 86 | 01-01-09 |
Director/Board Member | 75 | 01-04-13 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 2,12 | -4,50% | 138 155 |
18-04-24 | 2,22 | -5,13% | 202 895 |
17-04-24 | 2,34 | -8,59% | 295 342 |
16-04-24 | 2,56 | -7,91% | 455 858 |
15-04-24 | 2,78 | -0,71% | 315 039 |
uitgestelde koers Nasdaq, 19 april 2024 om 17:22 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+69,53% | 145 mln. | |
-3,00% | 102 mld. | |
+1,58% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,76% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-27,69% | 13,79 mld. | |
-0,01% | 13,33 mld. | |
+20,00% | 10,94 mld. |